Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-02-27 @ 2:21 PM
Study NCT ID:
NCT05323656
Status:
COMPLETED
Last Update Posted:
2025-09-02
First Post:
2022-04-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Sponsor:
Organization: